Benchmark, the global aquaculture, genetics, health and nutrition firm, posted a profit in the first quarter of its current fiscal year, coming off a radical of restructuring under CEO Trond Williksen.
Adjusted earnings before interest, tax, depreciation and amortization of continuing operations rose sharply to £3 million (€3.4 million/$4.2 million), resulting from stronger revenues, cost reductions and ongoing control of operating costs and R&D expenses.
